Skip to main content

Medical Management of Chronic Pain Caused by Cancer

  • Chapter
Supportive Care in Cancer Therapy

Part of the book series: Cancer Treatment and Research ((CTAR,volume 13))

  • 75 Accesses

Abstract

The patient with cancer may experience a number of distressing symptoms, the most common being that of pain. The generalization that pain is an inevitable consequence of cancer usually stems from an experience of having known someone with cancer who has suffered excruciating pain. In truth, most patients do not need to suffer pain. Successful palliation of patients with cancer pain is possible in 95–99% [1–3]. Nevertheless, for many cancer patients pain relief is far from optimal because of both inadequate knowledge and improper application of current knowledge.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bonica JJ: Cancer pain: the importance of the problem. In: Advances in Pain Research and Therapy, Vol. 2, Bonica JJ, Ventofridden V (eds). New York, Raven Press, 1979, pp 1–11.

    Google Scholar 

  2. Houcle RW: Pain and the patient with cancer. In: The Medical Clinics of North America — Symposium on the Medical Aspects of Cancer, Karnofsky DA, Rowson RW (eds). Philadelphia and London, WB Saunders Co, 1956, pp 687–703.

    Google Scholar 

  3. Shimm DS, Logue GL, Maltbie AA, Dugan S: Medical management of chronic cancer pain. JAMA 241: 2408–2412, 1979.

    PubMed  CAS  Google Scholar 

  4. Marks RM, Sachar EJ: Undertreatment of medical in-patients with narcotic analgesics. Ann Intern Med 78: 173–181, 1973.

    PubMed  CAS  Google Scholar 

  5. Saunders CM: Care of the terminal stages of cancer. Ann Royal Coll Surg (England), Volume 41.

    Google Scholar 

  6. Houde R, Fink BR: Management of pain of advanced cancer: systemic analgesics and related drugs. In: Advances in Pain Research and Therapy, Vol 2, Bonica JJ, Ventofridde V (eds). New York, Raven Press, 1979, pp 301–302.

    Google Scholar 

  7. Catalano RB: Supportive care of the seriously ill cancer patient: control of pain. In: Oncologic Emergencies, Yarbro JW, Bornstein RS (eds). New York, Grune amp; Stratton, 1981 pp 365–393.

    Google Scholar 

  8. Dant RL, Cleeland CS: The prevalence and severity of pain in cancer. Cancer 50: 1913–1918, 1982.

    Google Scholar 

  9. Oster MW, Vizel M, Turgeon MS: Pain of terminal cancer patients. Arch Intern Med 138: 1801–1802, 1978.

    PubMed  CAS  Google Scholar 

  10. Catalano RB: Medical management of pain caused by cancer. Semin Oncol 2: 379–392, 1975.

    PubMed  CAS  Google Scholar 

  11. DuBe’ SE: Hospice care and the pharmacist. US Pharmacist 2: 25–38, 1981.

    Google Scholar 

  12. Wilkes E: Some problems in cancer management. Proc R Soc Med 67: 23–27, 1974.

    Google Scholar 

  13. Twycross RG: Clinical management with dramorphine in advanced malignant disease. Int J Clin Pharmacol 93: 184–198, 1974.

    Google Scholar 

  14. Bonica JJ: Cancer pain: a major national health problem. Cancer Nurs J 4: 313–316, 1978.

    Google Scholar 

  15. Pannuti F, Martoni A, Rossi AP, Prana E: The role of endocrine therapy for relief of pain due to advanced cancer. In: Advances in Pain Research and Therapy, Vol 2, Bonica JJ, Ventofridden V (eds). New York, Raven Press, 1979, pp 00–00.

    Google Scholar 

  16. Parker CM: Home or hospital? Terminal care as seen by surviving spouse. J R Coll Gen Proct 28: 19–30, 1978.

    Google Scholar 

  17. Twycross RG: Choice of strong analgesic in terminal cancer: diamorphine or morphine? Pain 7: 93–104, 1977.

    Google Scholar 

  18. Silverberg E: Cancer statistics, 1982. Cancer — A Cancer Journal for Clinicians 32: 15–31.

    CAS  Google Scholar 

  19. Bonica JJ: Fundamental considerations of chronic pain therapy. Postgrad Med 53: 187–194, 1973.

    Google Scholar 

  20. Murphy TM: Cancer pain. Postgrad Med 53: 187–194, 1973.

    PubMed  CAS  Google Scholar 

  21. Roger DG: 21 problems in pain control and ways to solve them. Your Patient and Cancer: 65–69, 1981.

    Google Scholar 

  22. Black PM: Management of cancer pain: An overview. Neurosurg 5: 507–518, 1979.

    CAS  Google Scholar 

  23. Twycross RG: Overview of analgesia. In: Advances in Pain Research and Therapy, Vol 2, Bonica JJ, Ventofridden V (eds). New York, Raven Press, 1979, pp 617–633.

    Google Scholar 

  24. Foley KM: Pain syndrome in patients with cancer. In: Advances in Pain Research and Therapy, Vol 2, Bonica JJ, Ventofridden V (eds). New York, Raven Press, 1979, pp 59–75.

    Google Scholar 

  25. Bonica JJ: The management of pain. Philadelphia, Lea amp; Febeger, 1953.

    Google Scholar 

  26. Kennedy BJ, Fortuny IE: Therapeutic castration in the treatment of advanced breast cancer. Cancer 17: 1197–1202, 1964.

    PubMed  CAS  Google Scholar 

  27. Scott WW: Rationale and results of primary endocrine therapy in patients with prostatic cancer. Cancer 32: 1119–1125, 1973.

    PubMed  CAS  Google Scholar 

  28. Fracchia AA, Farrow JH, Miller TR: Hypophysectomy as compared to adenolectomy in treatment of advanced breast cancer. Surg Gynecol Obstet 133: 241, 1971.

    PubMed  CAS  Google Scholar 

  29. Murphy GP et al: Hypophysectomy and adrenalectomy for disseminated prostatic carcinoma. J Urol 105: 817–825, 1971.

    PubMed  CAS  Google Scholar 

  30. Parker RG: Pain relief for the cancer patients through selective radiation therapy. Northwest Med 69: 1022–1025, 1968.

    Google Scholar 

  31. Rubin P: Current concept in cancer: metastases and disseminated cancer. V. Bone. Int J Rad Oncol Bröl Phys 1: 1199–1200, 1976.

    Google Scholar 

  32. Tong D, Gillick L, Hendrickson FR: The palliation of symptomatic osseous metastases. Cancer 50: 839–899, 1982.

    Google Scholar 

  33. Horton J, Barter OH, Olsen KB: The management of metastases to brain by irradiation and corticosteroids. Am J Roentgenol Rad Ther Nucl Med 111: 334–336, 1971.

    CAS  Google Scholar 

  34. Weinstein EA: The effects of dexamethasone on brain edema in patients with metastatic brain tumours. Neurology 23: 121–129, 1973.

    PubMed  CAS  Google Scholar 

  35. Black P: Brain metastases: current status and recommended guidelines for management. Neurosurg 5: 617–631, 1979.

    CAS  Google Scholar 

  36. Cady B, Oberfield RA: Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. Am J Surg 127: 220–226, 1974.

    PubMed  CAS  Google Scholar 

  37. Mawsey WH, Fletcher WS, Judkins MP et al: Hepatic artery infusion for metastastic malignancy using percutaneous-placed catheters. Am J Surg 121: 160–164, 1971.

    Google Scholar 

  38. Ensminger W, Niederhuber J, Dakhel S, Thrall J, Wheeler R: Totally implanted drug delivery system for hepatic arterial chemotherapy. Cancer Treat Rep 65: 401–411, 1981.

    PubMed  Google Scholar 

  39. Halpern LH: Analgesic drugs in the management of pain. Arch Drug 112: 861–869, 1977.

    CAS  Google Scholar 

  40. Houde RW: Systemic analgesics and related drugs: narcotic analgesics. In: Advances in Pain Research and Therapy, Vol 2, Bonica JJ, Ventofridden V (eds). New York, Raven Press, 1979, pp 263–273.

    Google Scholar 

  41. Twycross RG: The Brompton cocktail. In: Advances in Pain Research and Therapy, Vol 2, Bonica JJ, Ventofridden V (eds). New York, Raven Press, 1979, pp 291–300.

    Google Scholar 

  42. Dawson DM, Fischer EG: Host effects of cancer: pain. In: Cancer Medicine, 2nd ed, Holland JF, Frei E (eds). Philadelphia, Lea amp; Febeger, 1982, pp 1205–1219.

    Google Scholar 

  43. Pert CB, Pasternak GW, Snyder SH: Opiate agonists and antagonists discriminated by receptor binding in brain. Science 182: 1359–1361, 1975.

    Google Scholar 

  44. Snyder SH: Opitate receptors in the brain. New Engl J Med 296: 266–271, 1977.

    PubMed  CAS  Google Scholar 

  45. Guillemin R: Endorphins, brain peptides that act like opiates. New Engl J Med 296: 226–228, 1977.

    PubMed  CAS  Google Scholar 

  46. Anon: Encephalins: the search for a functional role. Lancet, October 14: 819–820, 1978.

    Google Scholar 

  47. Snyder SH, Pert CB, Pasternak GW: The opiate receptor. Ann Intern Med 81: 534–540, 1974.

    PubMed  CAS  Google Scholar 

  48. Loh YP, Loriaux LL: Adrenocorticotropic hormone, B–lipotropian, and endorphin–related peptides in health and disease. JAMA 247: 1033–1034, 1982.

    PubMed  CAS  Google Scholar 

  49. West AB: Understanding endorphins: our natural pain relief system. Nursing 81: 50–53, 1981.

    Google Scholar 

  50. Higgs GA: Arachidonic acid metabolism, pain, and hyperalgesia: the mode of action of non-steroid mild analgesics. Br J Clin Pharmacol 10 (suppl 2): 2335–2353, 1980.

    Google Scholar 

  51. Ramwell PW: Biologic importance of arachidonic acid. Arch Intern Med 141: 275–279, 1981.

    PubMed  CAS  Google Scholar 

  52. Pruss AG: Evaluation of zomepirac. J Clin Pharmacol 20: 215–222, 1980.

    Google Scholar 

  53. Vandam LD: Analgetic drugs — the mild analgetics. New Engl J Med 286: 249–252, 1972.

    PubMed  CAS  Google Scholar 

  54. Richlin DM, Brand L: The use of oral analgesics for chronic pain. Hosp Formulary: 32–41, 1982.

    Google Scholar 

  55. Moertel CG, Ohmann DL, Taylor WF et al: A comparative evaluation of marketed analgesic drugs. New Engl J Med 286: 813–815, 1972.

    PubMed  CAS  Google Scholar 

  56. Moertel CG, Ohmann DL, Taylor WF et al: Relief of pain by oral medications. JAMA 229: 55–59, 1974.

    PubMed  CAS  Google Scholar 

  57. Beaver WT: Mild analgesics: a review of their clinical pharmacology. Part II. Am J Med Sci 251: 576–599, 1966.

    PubMed  CAS  Google Scholar 

  58. Abels: Analgesic nephropathy. Clin Pharmacol Ther 12: 583–587, 1971.

    Google Scholar 

  59. Goldberg M, Murray TG: Analgesic-associated nephropathy: an important cause of renal disease in the United States? New Engl J Med 299: 716–717, 1978.

    PubMed  CAS  Google Scholar 

  60. McLeod DC: Analgesic nephropathy. New Engl J Med 300: 319, 1979.

    Google Scholar 

  61. Perry DJ, Wood PHN: Relationship between aspirin taking and gastrointestinal hemorrhage. Gut 8: 301–308, 1967.

    Google Scholar 

  62. Chafee FH: Aspirin intolerance. I. Frequency in an allergic population. J Allergy Clin Immunol 53: 193–199, 1974.

    Google Scholar 

  63. Smith AP: Response of aspirin-allergic patients to challenge by some analgesics in common use. Br Med J 2: 494–496, 1971.

    PubMed  CAS  Google Scholar 

  64. Weiss HJ, Aledorf LM: Impaired platelet/connective tissue reaction in man after aspirin ingestion. Lancet 2: 499, 1967.

    Google Scholar 

  65. Harris WH et al: Aspirin prophylaxis of venous thromboembolism after total hip replacement. New Engl J Med 297: 1246, 1977.

    PubMed  CAS  Google Scholar 

  66. Horter HR et al: Prevention of thrombosis in patients on hemodialysis by low-dose heparin. New Engl J Med 301: 577, 1979.

    Google Scholar 

  67. Taylor F: Aspirin: America’s favorite drug. FDA Consumer 14 (10): 12, 1980.

    Google Scholar 

  68. Anon: Aspirin products. Medical Letter 23: 65, 1981.

    Google Scholar 

  69. Anon: Aspirin after myocardial infarction. Lancet 1: 1172, 1980.

    Google Scholar 

  70. Flower RJ, Moncada S, Vane JR: Analgesic-antipyretic and anti-inflammatory drugs. In: The Pharmacological Basis of Therapeutics, 6th ed, Gilman AG, Goodman LS, Gilman A (eds). New York, MacMillan Publishing Co, 1980, pp 682–728.

    Google Scholar 

  71. Ferreira SH: Inflammatory pain, prostaglandin hyperalgesia and the development of peripheral analgesics. Trends Pharmacol Sci 2: 183, 1981.

    CAS  Google Scholar 

  72. Ameer B, Greenblatt DJ: Acetaminophen. Ann Intern Med 87: 202–209, 1977.

    PubMed  CAS  Google Scholar 

  73. Koch-Weser J: Acetaminophen. New Engl J Med 295: 1297–13101, 1976.

    PubMed  CAS  Google Scholar 

  74. Cooper SH: Comparative analgesic efficacies of aspirin and acetaminophen. Arch Intern Med 141: 282–285, 1981.

    PubMed  CAS  Google Scholar 

  75. Mielke CH: Comparative effects of aspirin and acetaminophen on hemostasis. Arch Intern Med 141: 305–310, 1981.

    PubMed  CAS  Google Scholar 

  76. Jick H: Effects of aspirin and acetaminophen in gastrointestinal hemorrhage. Arch Intern Med 141: 316–320, 1981.

    PubMed  CAS  Google Scholar 

  77. Zimmerman HJ: Effects of aspirin or acetaminophen on the liver. Arch Intern Med 141: 333–341, 1981.

    PubMed  CAS  Google Scholar 

  78. Schreiner GE, MacNally JF, Winchester JE: Clinical analgesic nephropathy. Arch Intern Med 141: 349–357, 1981.

    PubMed  CAS  Google Scholar 

  79. Anon: Ibuprofen (Motrin) — a new drug for arthritis. Medical Letter 16: 109–110, 1974.

    Google Scholar 

  80. Kantor KG: Ibuprofen. Ann Intern Med 91: 877–882, 1979.

    PubMed  CAS  Google Scholar 

  81. Katz SM, Capaldo R, Everts EA, DiGregorio JG: Tolmetin, association with reversible renal failure and acute interstitial nephritis. JAMA 246: 243–245, 1981.

    PubMed  CAS  Google Scholar 

  82. Smith VT: Anaphylactic shock, acute renal failure and disseminated intravascular coagulation, suspected complication of zomepirac. JAMA 247: 1172–1173, 1982.

    PubMed  CAS  Google Scholar 

  83. Robertson CE, Ford KJ, Someran V: mefenamic acid nephropathy. Lancet 2: 232–233

    Google Scholar 

  84. Plotz PH, Kimberly RP: Acute effects of aspirin and acetaminophen on renal function. Arch Intern Med 141: 343–348, 1981.

    PubMed  CAS  Google Scholar 

  85. Lewis JR: Zomepirac sodium, A new non-addicting analgesic. JAMA 246:377–379

    Google Scholar 

  86. Cooper SA: Efficacy of zomepirac in oral surgical pain. J Clin Pharmacol 20: 230–242, 1980.

    PubMed  CAS  Google Scholar 

  87. Wallenstein SL, Rogers A, Karko RF et al: Relative analgesic potency of oral zomepirac and intramuscular morphine on cancer patients with postoperative pain. J Clin Pharmacol 20: 250–258, 1980.

    PubMed  CAS  Google Scholar 

  88. Stambaugh JE, Tejada F, Trudnowski RJ: Double-blind comparison of zomepirac and oxycodone with APC in cancer pain. J Clin Pharmacol 20: 261–270, 1980.

    PubMed  Google Scholar 

  89. Honig S: Preliminary report: long-term safety of zomepirac. J Clin Pharmacol 20: 392–396, 1980.

    PubMed  CAS  Google Scholar 

  90. Rouoff GE, Andelman SY, Cannella J J: Long-term safety of zomepirac: a double–blind comparison with aspirin in patients with osteoarthritis. J Clin Pharmacol 20: 377–384, 1980.

    Google Scholar 

  91. Cass LJ, Fredrich WS: Clinical comparison of the analgesic effects of dextropropoxyphene and other analgesics. Antibiot Med Clin Ther 6: 363–370, 1959.

    Google Scholar 

  92. Graber CM: The post-partum patients in evaluating analgesic drugs. Clin Pharmacol Ther 2: 429–440, 1961.

    Google Scholar 

  93. Procko LD: Evaluation of D-propoxyphene, codeine and aspirin. Obstet Gynecol 16: 113–118, 1960.

    Google Scholar 

  94. Berdon JK: The effectiveness of D-propoxyphene in the control of pain after peridontal surgery. J Periodont 39: 106–111, 1964.

    Google Scholar 

  95. Chilton NW: Double-blind evaluation of a new analgesic agent in post extraction pain. Am J Med Sci 242: 702–706, 1961.

    PubMed  CAS  Google Scholar 

  96. Hopkinson JH: Acetaminophen vs. propoxyphene for relief of pain in episiotomy patients. J Clin Pharmacol 7: 251–263, 1973.

    Google Scholar 

  97. Young DJ: Propoxyphene suicides. Arch Intern Med 129: 62–66, 1972.

    PubMed  CAS  Google Scholar 

  98. Beaver WT, Wallenstein SL, Houde RW: A clinical comparison of the effects of oral and intramuscular administration of analgesics: Pentazocine and phenazocine. Clin Pharmacol Ther 9: 582–597, 1968.

    PubMed  CAS  Google Scholar 

  99. Beaver WT, Wallenstein SL, Houde RW: A comparison of the analgesic effects of pentazocine and morphine in patients with cancer. Clin Pharmacol Ther 7: 740–751, 1966.

    PubMed  CAS  Google Scholar 

  100. Lewis JR: Misprescribing analgesics. JAMA 228: 1155–1156, 1974.

    PubMed  CAS  Google Scholar 

  101. Bellville JW, Green J: The respiratory and subjective efforts of pentazocine. Clin Pharmacol Ther 7: 740–751, 1966.

    Google Scholar 

  102. Reichenberg S, Pobers F: Severe respiratory depression following Talwin. Am Rev Resp Dis 107: 280–282, 1973.

    PubMed  CAS  Google Scholar 

  103. Vandam LD: Analgetic drugs — the potent analgetics. New Engl J Med 286: 249–251

    Google Scholar 

  104. Papper S, Papper EM: The effects of preanesthetics, anesthetics, and post–operative drugs on renal function. Clin Pharmacol Ther 5: 205, 1964.

    PubMed  CAS  Google Scholar 

  105. House RW, Wallenstein SL, Beaver WT: Clinical measurement of pain. In: Analgesics, de Stevens G (ed). New York, Academic Press, 1965, pp 75–122.

    Google Scholar 

  106. Bonica JJ: The total management of the patient with chronic pain. Drug Therapy 3:33–47

    Google Scholar 

  107. Holmes H: Morphine IV infusion for chronic pain. Drug Intell Clin Pharm 12:556

    Google Scholar 

  108. Ensworth S: Morphine IV infusion for chronic pain. Drug Intell Clin Pharm 13:297

    Google Scholar 

  109. Kowolenko M: Morphine IV infusion. Drug Intell Clin Pharm 14: 296–297, 1980.

    Google Scholar 

  110. Miser AW, Miser JS, Clark BS: Continuous IV infusion of morphine sulfate for control of severe pain in children with terminal malignancy. J Pediat 96: 930–932, 1980.

    PubMed  CAS  Google Scholar 

  111. Ruller PC, Murphy F, Dudley HAF: Morphine: controlled trial of different methods of administration for postoperative pain relief. Br Med J 1: 12–13, 1980.

    Google Scholar 

  112. Fraser DG: Intravenous morphine infusion for chronic pain. Ann Intern Med 93:781–782

    Google Scholar 

  113. Menard PJ: Use of continuous narcotic infusions. Am J Hosp Pharm 39: 1459–1460, 1982.

    PubMed  CAS  Google Scholar 

  114. Oyama T, Jin T, Yamaya R et al: Profound analgesic effects of B–endorphin in man. Lancet 1: 122–124, 1980.

    PubMed  CAS  Google Scholar 

  115. Leavens ME, Hill CS, Cech DA, Weyland JB, Weston JS: Intrathecal and intraventricular morphine for pain in cancer patients: initial study. J Neurosurg 56: 241–245, 1982.

    PubMed  CAS  Google Scholar 

  116. Poletti CE, Cohen AM, Todd DP, Ojemann RG, Sweet WH, Zervos NT: Cancer pain relieved by long-term epidural morphine with permanent indwelling systems for self- administration. J Neurosurg 55: 581–584, 1981.

    PubMed  CAS  Google Scholar 

  117. Onofrio BM, Yahsh TL, Arnold PG: Continuous low dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 56:516–520

    Google Scholar 

  118. Richelsen E: Spinal opiate administration for chronic pain: a major advance in therapy. Mayo Clin Proc 56: 523, 1981.

    Google Scholar 

  119. Yaksh TL: Spinal opiate analgesia: characteristics and principles of action. Pain 11: 293–346, 1981.

    PubMed  CAS  Google Scholar 

  120. Goldstein A: Opioid peptides (endorphins) in pituitary and brain. Science 193: 1081–1086, 1976.

    PubMed  CAS  Google Scholar 

  121. Snyder SH: Opiate receptors in the brain. New Engl J Med 296: 266–271, 1977.

    PubMed  CAS  Google Scholar 

  122. Anon: The Brompton cocktail. Lancet 1: 1220, 1979.

    Google Scholar 

  123. Glover DD, Lowry TF, Jacknowitz AI: Brompton’s mixture in alleviating pain of terminal neoplastic disease: preliminary results. South Med J 138: 278, 1980.

    Google Scholar 

  124. VanDyke C et al: Oral cocaine: plasma concentrations and central effects. Science 200: 211, 1979.

    Google Scholar 

  125. Wilkinson P et al: Intranasal and oral cocaine kinetics. Clin Pharmacol Ther 27: 386, 1980.

    PubMed  CAS  Google Scholar 

  126. Forrest WH et al: Dextroamphetamine with morphine for the treatment of post-operative pain. New Engl J Med 296: 712–715, 1977.

    PubMed  Google Scholar 

  127. Catalano RB: Personal communication, 1982.

    Google Scholar 

  128. Melzack R, Mount BM, Gorden JM: The Brompton mixture versus morphine solution given orally. Effects on pain. Canad Med Assoc J 2: 1348, 1977.

    Google Scholar 

  129. Twycross RG: Value of cocaine in opiate-containing elixirs. Br Med J 2: 1348, 1977.

    PubMed  CAS  Google Scholar 

  130. Karko RF, Wallenstein SL, Rogers AG, Grabinski PY, Houde RW: Analgesic and mood effects of heroin and morphine in cancer patients with postoperative pain. New Engl J Med 304: 1501–1505, 1981.

    Google Scholar 

  131. Lasagna L: Heroin: a medical ‘me too’. New Engl J Med 304: 1539–1540, 1981.

    PubMed  CAS  Google Scholar 

  132. Bennett R: Results are better when patients control their own analgesia. JAMA 247: 945–947, 1982.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Catalano, R.B. (1983). Medical Management of Chronic Pain Caused by Cancer. In: Higby, D.J. (eds) Supportive Care in Cancer Therapy. Cancer Treatment and Research, vol 13. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3864-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3864-2_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3866-6

  • Online ISBN: 978-1-4613-3864-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics